Galapagos NV
25.80
21-2月-25 09:35:01
15 分の遅延
株式
+0.38
+1.49%
本日の幅
25.60 - 25.86
ISIN
BE0003818359
ソース
Cboe
-
Galapagos 2021 results set stage for future growth
24 2 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Galapagos receives transparency notification from EcoR1 Capital
03 2 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
02 2 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Galapagos creates new subscription right plan
26 1 2022 16:40:00 提供 Nasdaq GlobeNewswire
-
Galapagos appoints Paul Stoffels as Chief Executive Officer
26 1 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
18 1 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Galapagos creates new subscription right plan
13 1 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Galapagos to present at 40th Annual J.P. Morgan Healthcare Conference
06 1 2022 09:30:00 提供 Nasdaq GlobeNewswire
-
Galapagos increases share capital through subscription right exercises
03 12 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
22 11 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
15 11 2021 10:45:07 提供 Nasdaq GlobeNewswire
-
Galapagos reports commercial and operational progress at Q3 financial results
04 11 2021 17:01:00 提供 Nasdaq GlobeNewswire
-
04 10 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
04 10 2021 01:01:00 提供 Nasdaq GlobeNewswire
-
Galapagos increases share capital through subscription right exercises
20 9 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
17 9 2021 07:15:00 提供 Nasdaq GlobeNewswire
-
Galapagos announces planned retirement of CEO
30 8 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Galapagos reports H1 financial results with refocused pipeline and operational progress
05 8 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
14 7 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
14 7 2021 16:01:00 提供 Nasdaq GlobeNewswire